Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease

References

• Wimo A, Prince M. World Alzheimer Report 2010: The Global Economic Impact of Dementia (London: Alzheimer's Disease International). 2010: p. 1-56.
   Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297:353 - 6; http://dx.doi.org/10.1126/science.1072994; PMID: 12130773
   PubMed Web of Science ®Google Scholar
• Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci 2012; 15:349 - 57; http://dx.doi.org/10.1038/nn.3028; PMID: 22286176
   PubMed Web of Science ®Google Scholar
• Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998; 95:6448 - 53; http://dx.doi.org/10.1073/pnas.95.11.6448; PMID: 9600986
   PubMed Web of Science ®Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416:535 - 9; http://dx.doi.org/10.1038/416535a; PMID: 11932745
   PubMed Web of Science ®Google Scholar
• Wang H-W, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, et al. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002; 924:133 - 40; http://dx.doi.org/10.1016/S0006-8993(01)03058-X; PMID: 11750898
   PubMed Web of Science ®Google Scholar
• Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14:837 - 42; http://dx.doi.org/10.1038/nm1782; PMID: 18568035
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Zou W-Q, Xiao X, Yuan J, Puoti G, Fujioka H, Wang X, et al. Amyloid-β42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem 2011; 286:15095 - 105; http://dx.doi.org/10.1074/jbc.M110.199356; PMID: 21393248
   PubMed Web of Science ®Google Scholar
• Chen S, Yadav SP, Surewicz WK. Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers. J Biol Chem 2010; 285:26377 - 83; http://dx.doi.org/10.1074/jbc.M110.145516; PMID: 20576610
   PubMed Web of Science ®Google Scholar
• Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A 2010; 107:2295 - 300; http://dx.doi.org/10.1073/pnas.0911829107; PMID: 20133875
   PubMed Web of Science ®Google Scholar
• Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2011; 2:336; http://dx.doi.org/10.1038/ncomms1341; PMID: 21654636
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 48; http://dx.doi.org/10.1016/S0092-8674(00)81163-0; PMID: 9590169
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057 - 70; http://dx.doi.org/10.1038/emboj.2011.86; PMID: 21441896
   PubMed Web of Science ®Google Scholar
• Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature 2010; 466:E3 - 4, discussion E4-5; http://dx.doi.org/10.1038/nature09217; PMID: 20703260
   PubMed Web of Science ®Google Scholar
• Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2010; 2:306 - 14; http://dx.doi.org/10.1002/emmm.201000082; PMID: 20665634
   PubMed Web of Science ®Google Scholar
• Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, et al. Alzheimer’s disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 2011; 31:7259 - 63; http://dx.doi.org/10.1523/JNEUROSCI.6500-10.2011; PMID: 21593310
   PubMed Web of Science ®Google Scholar
• Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer’s disease. Neurobiol Aging 1990; 11:29 - 37; http://dx.doi.org/10.1016/0197-4580(90)90059-9; PMID: 2325814
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367 - 74; http://dx.doi.org/10.1523/JNEUROSCI.0395-10.2010; PMID: 20445063
   PubMed Web of Science ®Google Scholar
• Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, et al. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer’s disease model mouse. BMC Neurosci 2010; 11:130; http://dx.doi.org/10.1186/1471-2202-11-130; PMID: 20946660
   PubMed Web of Science ®Google Scholar
• Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, et al. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15:1227 - 35; http://dx.doi.org/10.1038/nn.3178; PMID: 22820466
   PubMed Web of Science ®Google Scholar
• Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 2007; 27:796 - 807; http://dx.doi.org/10.1523/JNEUROSCI.3501-06.2007; PMID: 17251419
   PubMed Web of Science ®Google Scholar
• Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-beta. [beta] Nat Neurosci 2005; 8:1051 - 8; http://dx.doi.org/10.1038/nn1503; PMID: 16025111
   PubMed Web of Science ®Google Scholar
• Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP, et al. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 2006; 97:Suppl 1 16 - 23; http://dx.doi.org/10.1111/j.1471-4159.2005.03507.x; PMID: 16635246
   PubMed Web of Science ®Google Scholar
• Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer’s disease. Nature 2000; 408:975 - 9; http://dx.doi.org/10.1038/35046031; PMID: 11140684
   PubMed Web of Science ®Google Scholar
• Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274:99 - 102; http://dx.doi.org/10.1126/science.274.5284.99; PMID: 8810256
   PubMed Web of Science ®Google Scholar
• Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440:352 - 7; http://dx.doi.org/10.1038/nature04533; PMID: 16541076
   PubMed Web of Science ®Google Scholar
• Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005; 8:79 - 84; http://dx.doi.org/10.1038/nn1372; PMID: 15608634
   PubMed Web of Science ®Google Scholar
• Cissé M, Sanchez PE, Kim DH, Ho K, Yu GQ, Mucke L. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 2011; 31:10427 - 31; http://dx.doi.org/10.1523/JNEUROSCI.1459-11.2011; PMID: 21775587
   PubMed Web of Science ®Google Scholar
• Harris JA, Devidze N, Halabisky B, Lo I, Thwin MT, Yu GQ, et al. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer’s disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 2010; 30:372 - 81; http://dx.doi.org/10.1523/JNEUROSCI.5341-09.2010; PMID: 20053918
   PubMed Web of Science ®Google Scholar
• Deipolyi AR, Fang S, Palop JJ, Yu GQ, Wang X, Mucke L. Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol Aging 2008; 29:253 - 66; http://dx.doi.org/10.1016/j.neurobiolaging.2006.10.021; PMID: 17126954
   PubMed Web of Science ®Google Scholar
• Park JH, Widi GA, Gimbel DA, Harel NY, Lee DH, Strittmatter SM. Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer’s transgenic mice. J Neurosci 2006; 26:13279 - 86; http://dx.doi.org/10.1523/JNEUROSCI.4504-06.2006; PMID: 17182778
   PubMed Web of Science ®Google Scholar
• Cabrejo L, Guyant-Maréchal L, Laquerrière A, Vercelletto M, De la Fournière F, Thomas-Antérion C, et al. Phenotype associated with APP duplication in five families. Brain 2006; 129:2966 - 76; http://dx.doi.org/10.1093/brain/awl237; PMID: 16959815
   PubMed Web of Science ®Google Scholar
• Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in patients with Alzheimer’s disease. Epilepsia 2006; 47:867 - 72; http://dx.doi.org/10.1111/j.1528-1167.2006.00554.x; PMID: 16686651
   PubMed Web of Science ®Google Scholar
• Sinforiani E, Manni R, Bernasconi L, Banchieri LM, Zucchella C. Memory disturbances and temporal lobe epilepsy simulating Alzheimer’s disease: a case report. Funct Neurol 2003; 18:39 - 41; PMID: 12760413
   PubMed Web of Science ®Google Scholar
• Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 2007; 55:697 - 711; http://dx.doi.org/10.1016/j.neuron.2007.07.025; PMID: 17785178
   PubMed Web of Science ®Google Scholar
• Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13:513 - 609; http://dx.doi.org/10.1146/annurev.cellbio.13.1.513; PMID: 9442882
   PubMed Web of Science ®Google Scholar
• Hunter T. A tail of two src’s: mutatis mutandis. Cell 1987; 49:1 - 4; http://dx.doi.org/10.1016/0092-8674(87)90745-8; PMID: 3030562
   PubMed Web of Science ®Google Scholar
• Wu G-M, Hou X-Y. Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield. Brain Res 2010; 1343:186 - 93; http://dx.doi.org/10.1016/j.brainres.2010.04.055; PMID: 20441772
   PubMed Web of Science ®Google Scholar
• Chin J, Palop JJ, Puoliväli J, Massaro C, Bien-Ly N, Gerstein H, et al. Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer’s disease. J Neurosci 2005; 25:9694 - 703; http://dx.doi.org/10.1523/JNEUROSCI.2980-05.2005; PMID: 16237174
   PubMed Web of Science ®Google Scholar
• Prybylowski K, Chang K, Sans N, Kan L, Vicini S, Wenthold RJ. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 2005; 47:845 - 57; http://dx.doi.org/10.1016/j.neuron.2005.08.016; PMID: 16157279
   PubMed Web of Science ®Google Scholar
• Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 2010; 142:387 - 97; http://dx.doi.org/10.1016/j.cell.2010.06.036; PMID: 20655099
   PubMed Web of Science ®Google Scholar
• Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004; 7:221 - 8; http://dx.doi.org/10.1038/nn1188; PMID: 14966521
   PubMed Web of Science ®Google Scholar
• Pantera B, Bini C, Cirri P, Paoli P, Camici G, Manao G, et al. PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway. J Neurochem 2009; 110:194 - 207; http://dx.doi.org/10.1111/j.1471-4159.2009.06123.x; PMID: 19457127
   PubMed Web of Science ®Google Scholar
• Stuermer CA, Langhorst MF, Wiechers MF, Legler DF, Von Hanwehr SH, Guse AH, et al. PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J 2004; 18:1731 - 3; PMID: 15345693
   PubMed Web of Science ®Google Scholar
• Bizat N, Peyrin JM, Haïk S, Cochois V, Beaudry P, Laplanche JL, et al. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci 2010; 30:5394 - 403; http://dx.doi.org/10.1523/JNEUROSCI.5831-09.2010; PMID: 20392961
   PubMed Web of Science ®Google Scholar
• Málaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, et al. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 2009; 7:e55; http://dx.doi.org/10.1371/journal.pbio.1000055; PMID: 19278297
   PubMed Web of Science ®Google Scholar
• Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004; 5:317 - 28; http://dx.doi.org/10.1038/nrn1368; PMID: 15034556
   PubMed Web of Science ®Google Scholar
• Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, et al. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum Mol Genet 2012; 21:1138 - 44; http://dx.doi.org/10.1093/hmg/ddr542; PMID: 22100763
   PubMed Web of Science ®Google Scholar
• You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, et al. Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 2012; 109:1737 - 42; http://dx.doi.org/10.1073/pnas.1110789109; PMID: 22307640
   PubMed Web of Science ®Google Scholar